Neuromuscular block and current treatment strategies for its reversal in children

Paediatric Anaesthesia

Volumn 20, Issue 7, 2010, Pages 591-604

  Meretoja, Olli A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Children; Neostigmine; Neuromuscular block; Pharmacoeconomics; Reversal; Sugammadex

Indexed keywords

ATRACURIUM; CHOLINESTERASE INHIBITOR; EDROPHONIUM; MUSCLE RELAXANT AGENT; NEOSTIGMINE; PANCURONIUM; PYRIDOSTIGMINE; ROCURONIUM; SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE;

DRUG EFFECT; ENDOTRACHEAL INTUBATION; HUMAN; NEUROMUSCULAR BLOCKING; POSTANESTHESIA CARE; PRIORITY JOURNAL; REVIEW; ANESTHETIC RECOVERY; CHILD; INFANT; PEDIATRICS; PRESCHOOL CHILD; PROCEDURES;

ANESTHESIA RECOVERY PERIOD; CHILD; CHILD, PRESCHOOL; CHOLINESTERASE INHIBITORS; GAMMA-CYCLODEXTRINS; HUMANS; INFANT; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; PEDIATRICS;

EID: 77953850870     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2010.03335.x     Document Type: Review

References (124)

1. Hughes BW, Kusner LL, Kaminski HJ. Molecular architecture of the neuromuscular junction. Muscle Nerve 2006 33 : 445 461.
2. Wareham AC, Morton RH, Meakin GH. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat. Br J Anaesth 1994 72 : 205 209.
3. Kelly SS, Roberts DV. The effect of age on the safety factor in neuromuscular transmission in the isolated diaphragm of the rat. Br J Anaesth 1977 49 : 217 222.
4. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth Intensive Care 1990 18 : 440 448.
5. Meretoja OA, Taivainen T, Jalkanen L et al. Synergism between atracurium and vecuronium in infants and children during nitrous oxide-oxygen-alfentanil anaesthesia. Br J Anaesth 1994 73 : 605 607.
6. Fortier LP, Robitaille R, Donati F. Increased sensitivity to depolarization and nondepolarizing neuromuscular blocking agents in young rat hemidiaphragms. Anesthesiology 2001 95 : 478 484.
7. Lee HJ, Kim KS, Jeong JS et al. Comparison of the adductor pollicis, orbicularis oculi, and corrugator supercilii as indicators of adequacy of muscle relaxation for tracheal intubation. Br J Anaesth 2009 102 : 869 874.
8. Bragg P, Fisher DM, Shi J et al. Comparison of twitch depression of the adductor pollicis and the respiratory muscles pharmacodynamic modeling without plasma concentrations. Anesthesiology 1994 80 : 310 319.
9. Rizzoli SO, Betz WJ. The structural organization of the readily releasable pool of synaptic vesicles. Science 2004 303 : 2037 2039.
10. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004 27 : 509 547.
11. Caldwell JE. Clinical limitations of acetylcholinesterase inhibitors. J Crit Care 2009 24 : 21 28.
12. Jonsson M, Gurley D, Dabrowski M et al. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade. Anesthesiology 2006 105 : 521 533.
13. Bonsu AK, Viby-Mogensen J, Fernando PU et al. Relationship of post-tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium. Br J Anaesth 1987 59 : 1089 1092.
14. Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth 1989 62 : 274 278.
15. Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology 1976 45 : 216 249.
16. Eriksson LI, Lennmarken C, Staun P et al. Use of post-tetanic count in assessment of a repetitive vecuronium-induced neuromuscular block. Br J Anaesth 1990 65 : 487 493.
17. Gwinnutt CL, Meakin G. Use of the post-tetanic count to monitor recovery from intense neuromuscular blockade in children. Br J Anaesth 1988 61 : 547 550.
18. Baykara N, Woelfel S, Fine GF et al. Predicting recovery from deep neuromuscular block by rocuronium in children and adults. J Clin Anesth 2002 14 : 214 217.
19. Paton WD, Waud DR. The margin of safety of neuromuscular transmission. J Physiol 1967 191 : 59 90.
20. Waud DR, Waud BE. In vitro measurement of margin of safety of neuromuscular transmission. Am J Physiol 1975 229 : 1632 1634.
21. Bevan DR. Neuromuscular blocking drugs: onset and intubation. J Clin Anesth 1997 9 (6 Suppl 36S 39S.
22. Nava-Ocampo AA, Velazquez-Armenta Y, Moyao-Garcia D et al. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium. Clin Exp Pharmacol Physiol 2006 33 : 125 130.
23. Eikermann M, Hunkemoller I, Peine L et al. Optimal rocuronium dose for intubation during inhalation induction with sevoflurane in children. Br J Anaesth 2002 89 : 277 281.
24. Meakin GH, Meretoja OA, Perkins RJ et al. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia. Paediatr Anaesth 2007 17 : 113 120.
25. Erkola O, Rautoma P, Meretoja OA. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 1996 84 : 562 565.
26. Al-Alami AA, Ayoub CM, Baraka AS. Laryngospasm: review of different prevention and treatment modalities. Paediatr Anaesth 2008 18 : 281 288.
27. Black AE. Laryngospasm in pediatric practice. Paediatr Anaesth 2008 18 : 279 280.
28. Rawicz M, Brandom BW, Wolf A. The place of suxamethonium in pediatric anesthesia. Paediatr Anaesth 2009 19 : 561 570.
29. Brandom BW, Meretoja OA, Simhi E et al. Age related variability in the effects of mivacurium in paediatric surgical patients. Can J Anaesth 1998 45 : 410 416.
30. Brandom BW, Fine GF. Neuromuscular blocking drugs in pediatric anesthesia. Anesthesiol Clin North America 2002 20 : 45 58.
31. Meretoja OA. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants? Br J Anaesth 1989 62 : 184 187.
32. Pedersen T, Viby-Mogensen J, Ringsted C. Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand 1992 36 : 812 818.
33. Berg H, Roed J, Viby-Mogensen J et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997 41 : 1095 1103.
34. Murphy GS, Szokol JW, Marymont JH et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008 107 : 130 137.
35. Arbous MS, Meursing AE, van Kleef JW et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005 102 : 257 268.
36. Kopman AF. Undetected residual neuromuscular block has consequences. Anesthesiology 2008 109 : 363 364.
37. Kopman AF. Residual neuromuscular block and adverse respiratory events. Anesth Analg 2008 107 : 1756.
38. Ali HH, Wilson RS, Savarese JJ et al. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth 1975 47 : 570 574.
39. Eriksson LI, Lennmarken C, Wyon N et al. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992 36 : 710 715.
40. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993 78 : 693 699.
41. Eriksson LI, Sundman E, Olsson R et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997 87 : 1035 1043.
42. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997 86 : 765 771.
43. Sundman E, Witt H, Olsson R et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000 92 : 977 984.
44. Meretoja OA, Gebert R. Postoperative neuromuscular block following atracurium or alcuronium in children. Can J Anaesth 1990 37 : 743 746.
45. Murphy GS, Szokol JW, Marymont JH et al. Residual paralysis at the time of tracheal extubation. Anesth Analg 2005 100 : 1840 1845.
46. Murphy GS, Szokol JW, Marymont JH et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008 109 : 389 398.
47. Srivastara A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009 103 : 115 129.
48. Hayes AH, Mirakhur RK, Breslin DS et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001 56 : 312 318.
49. Kim KS, Lew SH, Cho HY et al. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg 2002 95 : 1656 1660.
50. Baillard C, Gehan G, Reboul-Maty J et al. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000 84 : 394 395.
51. Debaene B, Plaud B, Dilly MP et al. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003 98 : 1042 1048.
52. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007 62 : 806 809.
53. Meretoja OA. Muscle relaxants in children. In : Bissonnette B, Dalens BJ, eds. Pediatric anesthesia, principles & practice.
54. Meretoja OA, Wirtavuori K, Taivainen T et al. Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 1996 76 : 235 238.
55. Woloszczuk-Gebicka B. Mivacurium infusion requirement and spontaneous recovery of neuromuscular transmission in children anaesthetized with nitrous oxide and fentanyl, halothane, isoflurane or sevoflurane. Paediatr Anaesth 2002 12 : 511 518.
56. Abdulatif M, Mowafi H, Al-Ghamdi A et al. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. Br J Anaesth 1996 77 : 710 715.
57. Barber HE, Calvey TN, Muir KT. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium. Br J Pharmacol 1979 66 : 525 530.
58. Meakin G, Sweet PT, Bevan JC et al. Neostigmine and edrophonium as antagonists of pancuronium in infants and children. Anesthesiology 1983 59 : 316 321.
59. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg 1987 66 : 594 598.
60. Donati F, Smith CE, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 1989 68 : 13 19.
61. Smith CE, Donati F, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Anesthesiology 1989 71 : 37 43.
62. Naguib M, Abdulatif M, Al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Anesthesiology 1993 79 : 739 745.
63. Naguib M, Abdulatif M, Al-Ghamdi A et al. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Br J Anaesth 1993 71 : 709 714.
64. Naguib M, Riad W. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block. Can J Anaesth 2000 47 : 1074 1081.
65. Bom A, Bradley M, Cameron K et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed 2002 41 : 266 270.
66. Adam JM, Bennett DJ, Bom A et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Medicinal Chem 2002 45 : 1806 1816.
67. Bom A, Clark JK, Palin R. New approaches to reversal of neuromuscular block. Curr Opin Drug Discov Devel 2002 5 : 793 800.
68. Sparr HJ, Vermeyen KM, Beaufort AM et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007 106 : 935 943.
69. Bom A, Hope F, Rutherford S et al. Preclinical pharmacology of sugammadex. J Crit Care 2009 24 : 29 35.
70. Ploeger BA, Smeets J, Strougo A et al. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Anesthesiology 2009 110 : 95 105.
71. Beemer GH, Bjorksten AR, Dawson PJ et al. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 1991 66 : 469 475.
72. Bevan JC, Collins L, Fowler C et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg 1999 89 : 333 339.
73. Cronnelly R, Morris RB, Miller RD. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia. Anesthesiology 1982 57 : 261 266.
74. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P et al. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block. J Clin Anesth 1995 7 : 635 639.
75. Magorian TT, Lynam DP, Caldwell JE et al. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?. Anesthesiology 1990 73 : 410 414.
76. Pino RM. Residual neuromuscular blockade: a persistent clinical problem. Int Anesthesiol Clin 2006 44 : 77 90.
77. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988 69 : 272 276.
78. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007 98 : 302 316.
79. Ansermino JM, Sanderson PM, Bevan JC et al. Acceleromyography improves detection of residual neuromuscular blockade in children. Can J Anaesth 1996 43 : 589 594.
80. Hunter JM. Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults? Br J Anaesth 1996 77 : 707 709.
81. Fisher DM, Cronnelly R, Miller RD et al. The neuromuscular pharmacology of neostigmine in infants and children. Anesthesiology 1983 59 : 220 225.
82. Meretoja OA, Taivainen T, Wirtavuori K. Cisatracurium during halothane and balanced anaesthesia in children. Paediatr Anaesth 1996 6 : 373 378.
83. Meistelman C, Debaene B, d'Hollander A et al. Importance of the level of paralysis recovery for a rapid antagonism of vecuronium with neostigmine in children during halothane anesthesia. Anesthesiology 1988 69 : 97 99.
84. Debaene B, Meistelman C, d'Hollander A. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia. Anesthesiology 1989 71 : 840 844.
85. Gwinnutt CL, Walker RW, Meakin G. Antagonism of intense atracurium-induced neuromuscular block in children. Br J Anaesth 1991 67 : 13 16.
86. Baxter MR, Bevan JC, Samuel J et al. Postoperative neuromuscular function in pediatric day-care patients. Anesth Analg 1991 72 : 504 508.
87. Kirkegaard-Nielsen H, Meretoja OA, Wirtavuori K. Reversal of atracurium-induced neuromuscular block in paediatric patients. Acta Anaesthesiol Scand 1995 39 : 906 911.
88. Brandom BW, Taiwo OO, Woelfel SK et al. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium. Anesth Analg 1996 82 : 999 1002.
89. Viby-Mogensen J, Jensen NH, Engbaek J et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985 63 : 440 443.
90. Fuchs-Buder T, Meistelman C, Alla F et al. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology 2010 112 : 34 40.
91. Woloszczuk-Gebicka B, Wyska E, Grabowski T. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis. Paediatr Anaesth 2007 17 : 637 646.
92. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002 96 : 45 50.
93. Beemer GH, Goonetilleke PH, Bjorksten AR. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery. Anesthesiology 1995 82 : 852 858.
94. Bevan JC, Tousignant C, Stephenson C et al. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. Anesthesiology 1996 84 : 354 361.
95. Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006 97 : 123 126.
96. Cozanitis DA, Dundee JW, Merrett JD et al. Evaluation of glycopyrrolate and atropine as adjuncts to reversal of non-depolarizing neuromuscular blocking agents in a "true-to-life" situation. Br J Anaesth 1980 52 : 85 89.
97. van Vlymen JM, Parlow JL. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth Analg 1997 84 : 148 154.
98. Abrishami A, Ho J, Wong J et al. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev 2009 4 : CD007362.
99. Cammu G, De Kam PJ, Demeyer I et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth 2008 100 : 373 379.
100. Gijsenbergh F, Ramael S, Houwing N et al. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005 103 : 695 703.
101. Sorgenfrei IF, Norrild K, Larsen PB et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006 104 : 667 674.
102. Eleveld DJ, Kuizenga K, Proost JH et al. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007 104 : 582 584.
103. Groudine SB, Soto R, Lien C et al. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007 104 : 555 562.
104. Shields M, Giovannelli M, Mirakhur RK et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006 96 : 36 43.
105. Plaud B, Meretoja O, Hofmockel R et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009 110 : 284 294.
106. Pühringer FK, Rex C, Sielenkamper AW et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008 109 : 188 197.
107. de Boer HD, Driessen JJ, Marcus MA et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007 107 : 239 244.
108. Jones RK, Caldwell JE, Brull SJ et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008 109 : 816 824.
109. Lee C, Jahr JS, Candiotti KA et al. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009 110 : 1020 1025.
110. Kopman AF, Zhaku B, Lai KS. The "intubating dose" of succinylcholine: the effect of decreasing doses on recovery time. Anesthesiology 2003 99 : 1050 1054.
111. Vanacker BF, Vermeyen KM, Struys MM et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007 104 : 563 568.
112. Rex C, Wagner S, Spies C et al. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Anesthesiology 2009 111 : 30 35.
113. White PF, Tufanogullari B, Sacan O et al. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. Anesth Analg 2009 108 : 846 851.
114. Staals LM, Snoeck MM, Driessen JJ et al. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008 101 : 492 497.
115. Robertson EN, Driessen JJ, Booij LHDJ. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesthesiol 2005 22 : 4 10.
116. Sacan O, White PF, Tufanogullari B et al. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007 104 : 569 574.
117. Flockton EA, Mastronardi P, Hunter JM et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth 2008 100 : 622 630.
118. Suy K, Morias K, Cammu G et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007 106 : 283 288.
119. de Boer HD, Driessen JJ, van Egmond J et al. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anaesth 2008 55 : 124 126.
120. http://www.ema.europa.eu/humandocs/PDFs/EPAR/bridion/emea-combined- h885en.pdf Accessed 26 May, 2010.
121. Torkki P, Peltokorpi A, Alho A et al. Leikkaustoiminnan tehokkuutta tulisi mitata panos-tuotossuhteen avulla (Efficiency of operation room activities should be measured by input-output relationship). Finnish Medical J 2007 62 : 3765 3768.
122. Hari T, Jousela I, Marjamaa R et al. Leikkaustoiminnan tehokkuuden mittarit (Instruments for the efficiency of operation room activities). Sitra publications, Helsinki 2008 (Available at http://www.sitra.fi/julkaisut/muut/ HUS%20Leikkaustoiminnan%20mittarit%20Tiivistelmä.pdf?download=Lataa+pdf Accessed 26 May, 2010.
123. Brull SJ. Patient safety revisited: reliability is paramount. Anesth Analg 2009 108 : 702 703.
124. Miller RD. Sugammadex: an opportunity to change the practice of anesthesiology? Anesth Analg 2007 104 : 477 478.